相关实验视频
Updated: Sep 9, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.8K
全球喘倡议指南对12岁及以上青少年喘控制的方法进行比较
Danish Abdul Aziz1, Werdah Viquar1
1Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi.
概括
全球喘倡议 (GINA) 的指导方针建议在儿童喘治疗中使用低剂量吸入性皮质类固醇 (ICS) 与formoterol (轨道1) 相比,使用替代策略 (轨道2). 在青少年中显著减少了再入院,急诊和改善了肺功能.
科学领域:
- 儿童肺病学
- 呼吸系统医学
- 临床药理学
背景情况:
- 青少年 (12岁以上) 的喘管理遵循全球喘倡议 (GINA) 的两个轨道.
- 轨道1:根据需要使用低剂量的吸入性皮质类固醇 (ICS) 和formoterol.
- 轨道2:根据需要使用短效β-激动剂 (第一步) 和低剂量维持性ICS (第二步).
研究的目的:
- 在12岁及以上的儿科患者中比较GINA Track 1与Track 2治疗喘的有效性.
- 根据不同的基于GINA指南的治疗策略评估临床结果和肺功能.
主要方法:
- 巴基斯坦卡拉奇阿迦汗大学医院的回顾性研究 (2022年1月至2023年12月).
- 包括90名儿童喘患者 (12岁以上) 接受GINA Steps 1/2缓解剂治疗.
- 评估30天再入院,急诊,每年入院,重症监护和肺功能测试 (PFT) 在1周和3个月.
主要成果:
- 与第2轨道 (n=47) 相比,第1轨道 (n=43) 的再入院人数显著减少 (4.65%与19.15%,p=0.036) 和急救室的访问人数 (1.69±1.31与2.8±1.37,p<0.001).
- 轨道1需要更少的重症监护 (9.3%与27.66%,p=0.034) 和更少的住院 (1.37±0.85与2.1±0.84,p<0.001).
- 在出院3个月后,在轨道1观察到FEV1 (p=0. 026) 和FEV1/ FVC比率 (p< 0. 001) 的较大改善.
结论:
- 根据需要的ICS/formoterol (GINA轨道1) 在12岁及以上的青少年中更有效地治疗喘.
- 这一策略与轨道2相比,导致更好的临床结果和改善的肺功能.
- 支持采用GINA轨道1作为这个年龄组的首选治疗方案.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:30Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K